Skip to Main Content
Mental Health & Behavioral Research | Obesity & Weight Control, Phase I-II

GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight

What is the purpose of this trial?

If you are between 18 and 55 years of age and are overweight or have obesity you may qualify for a clinical trial evaluating a once weekly medication which may help with weight loss. The SEMA trial is funded by the National Institutes of Health (NIH) and the study medication (semaglutide vs. placebo) is provided at no cost to qualifying participants. Participants with diabetes are not eligible for this study.

  • Trial with
    National Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
  • Ages
    18 years - 55 years
  • Gender

Contact Information

For more information about this study, including how to volunteer, contact Rachel Hart

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact, or call 877.978.8343 for more information.

  • Last Updated
  • Study HIC